These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30327431)

  • 1. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the
    Hintze J; Ye Z; Narimatsu Y; Madsen TD; Joshi HJ; Goth CK; Linstedt A; Bachert C; Mandel U; Bennett EP; Vakhrushev SY; Schjoldager KT
    J Biol Chem; 2018 Dec; 293(49):19064-19077. PubMed ID: 30327431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Regulation of Protein O-Glycosylation in Isogenic Human HEK293 Cells by Differential O-Glycoproteomics.
    Narimatsu Y; Joshi HJ; Schjoldager KT; Hintze J; Halim A; Steentoft C; Nason R; Mandel U; Bennett EP; Clausen H; Vakhrushev SY
    Mol Cell Proteomics; 2019 Jul; 18(7):1396-1409. PubMed ID: 31040225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.
    Schjoldager KT; Joshi HJ; Kong Y; Goth CK; King SL; Wandall HH; Bennett EP; Vakhrushev SY; Clausen H
    EMBO Rep; 2015 Dec; 16(12):1713-22. PubMed ID: 26566661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.
    Kong Y; Joshi HJ; Schjoldager KT; Madsen TD; Gerken TA; Vester-Christensen MB; Wandall HH; Bennett EP; Levery SB; Vakhrushev SY; Clausen H
    Glycobiology; 2015 Jan; 25(1):55-65. PubMed ID: 25155433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
    Schjoldager KT; Vakhrushev SY; Kong Y; Steentoft C; Nudelman AS; Pedersen NB; Wandall HH; Mandel U; Bennett EP; Levery SB; Clausen H
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9893-8. PubMed ID: 22566642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
    Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
    J Virol; 2024 Jun; 98(6):e0052424. PubMed ID: 38757972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative mapping of the in vivo O-GalNAc glycoproteome in mouse tissues identifies GalNAc-T2 O-glycosites in metabolic disorder.
    Yang W; Tian E; Chernish A; McCluggage P; Dalal K; Lara A; Ten Hagen KG; Tabak LA
    Proc Natl Acad Sci U S A; 2023 Oct; 120(43):e2303703120. PubMed ID: 37862385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Schjoldager KT; Clausen H
    Biochim Biophys Acta; 2012 Dec; 1820(12):2079-94. PubMed ID: 23022508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo mapping of the mouse Galnt3-specific O-glycoproteome.
    Dalal K; Yang W; Tian E; Chernish A; McCluggage P; Lara AJ; Ten Hagen KG; Tabak LA
    J Biol Chem; 2024 Sep; 300(9):107628. PubMed ID: 39098533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ser and Thr acceptor preferences of the GalNAc-Ts vary among isoenzymes to modulate mucin-type O-glycosylation.
    Daniel EJP; Las Rivas M; Lira-Navarrete E; García-García A; Hurtado-Guerrero R; Clausen H; Gerken TA
    Glycobiology; 2020 Oct; 30(11):910-922. PubMed ID: 32304323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
    Ballard CJ; Paserba MR; Paul Daniel EJ; Hurtado-Guerrero R; Gerken TA
    Glycobiology; 2023 Oct; 33(10):817-836. PubMed ID: 37555669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-glycan initiation directs distinct biological pathways and controls epithelial differentiation.
    Bagdonaite I; Pallesen EM; Ye Z; Vakhrushev SY; Marinova IN; Nielsen MI; Kramer SH; Pedersen SF; Joshi HJ; Bennett EP; Dabelsteen S; Wandall HH
    EMBO Rep; 2020 Jun; 21(6):e48885. PubMed ID: 32329196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
    Steentoft C; Vakhrushev SY; Joshi HJ; Kong Y; Vester-Christensen MB; Schjoldager KT; Lavrsen K; Dabelsteen S; Pedersen NB; Marcos-Silva L; Gupta R; Bennett EP; Mandel U; Brunak S; Wandall HH; Levery SB; Clausen H
    EMBO J; 2013 May; 32(10):1478-88. PubMed ID: 23584533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GalNAc-type O-Glycoproteome of CHO cells characterized by the SimpleCell strategy.
    Yang Z; Halim A; Narimatsu Y; Jitendra Joshi H; Steentoft C; Schjoldager KT; Alder Schulz M; Sealover NR; Kayser KJ; Paul Bennett E; Levery SB; Vakhrushev SY; Clausen H
    Mol Cell Proteomics; 2014 Dec; 13(12):3224-35. PubMed ID: 25092905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates human δ-opioid receptor turnover at the plasma membrane.
    Lackman JJ; Goth CK; Halim A; Vakhrushev SY; Clausen H; Petäjä-Repo UE
    Cell Signal; 2018 Jan; 42():184-193. PubMed ID: 29097258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.
    Gerken TA; Revoredo L; Thome JJ; Tabak LA; Vester-Christensen MB; Clausen H; Gahlay GK; Jarvis DL; Johnson RW; Moniz HA; Moremen K
    J Biol Chem; 2013 Jul; 288(27):19900-14. PubMed ID: 23689369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates.
    Gerken TA; Raman J; Fritz TA; Jamison O
    J Biol Chem; 2006 Oct; 281(43):32403-16. PubMed ID: 16912039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific
    Goth CK; Tuhkanen HE; Khan H; Lackman JJ; Wang S; Narimatsu Y; Hansen LH; Overall CM; Clausen H; Schjoldager KT; Petäjä-Repo UE
    J Biol Chem; 2017 Mar; 292(11):4714-4726. PubMed ID: 28167537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.
    Raman J; Guan Y; Perrine CL; Gerken TA; Tabak LA
    Glycobiology; 2012 Jun; 22(6):768-77. PubMed ID: 22186971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3.
    Wandall HH; Hassan H; Mirgorodskaya E; Kristensen AK; Roepstorff P; Bennett EP; Nielsen PA; Hollingsworth MA; Burchell J; Taylor-Papadimitriou J; Clausen H
    J Biol Chem; 1997 Sep; 272(38):23503-14. PubMed ID: 9295285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.